MRI coverage decision
This article was originally published in The Gray Sheet
CMS will allow local Medicare contractors to cover magnetic resonance imaging for measuring cardiac blood flow under a Sept. 28 1final decision. Until now, MRI for this purpose has been non-covered nationally. However, CMS is still forbidding coverage for MRI in patients who have a cardiac pacemaker. Medtronic, which is pursuing U.S. approval for its MRI-safe EnRhythm MRI SureScan pacemaker, had asked CMS to permit coverage for MRI procedures in patients with pacemakers or defibrillators that have been FDA-approved for use in an MRI environment (2"The Gray Sheet" July 6, 2009). CMS said Medtronic's request was "premature," since no MRI-safe pacemakers or ICDs have yet received FDA approval. Medtronic told "The Gray Sheet" that it expects to gain approval for EnRhythm and launch it in the U.S. by October 2010
You may also be interested in...
Use of magnetic resonance imaging to assess heart valve disease in Medicare patients may be an easier proposition for physicians if a June 30 CMS coverage 1proposal is adopted
Keeping Track: Submissions Galore Start The New Year; US FDA Clears New Indications For Enhertu, Xalkori
The latest drug development news and highlights from the Pink Sheet US FDA Performance Tracker
Vacci Prep is first “supplement to establish a standard of care for consumers when preparing their immune system for vaccinations,” Dentovations says.